Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

ADRP antibody (Biotin)

The Biotin-conjugated Rabbit Polyclonal anti-ADRP antibody (ABIN6352667) specifically detects ADRP in WB, IHC and IF/ICC. The antibody is reactive with Human samples.
Catalog No. ABIN6352667
$549.66
Plus shipping costs $50.00
Shipping to: United States
Delivery in 10 to 20 Business Days

Quick Overview for ADRP antibody (Biotin) (ABIN6352667)

Target

See all ADRP (PLIN2) Antibodies
ADRP (PLIN2) (Perilipin 2 (PLIN2))

Reactivity

  • 141
  • 32
  • 23
  • 2
Human

Host

  • 83
  • 53
  • 5
  • 1
Rabbit

Clonality

  • 83
  • 59
Polyclonal

Conjugate

  • 60
  • 11
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This ADRP antibody is conjugated to Biotin

Application

  • 94
  • 64
  • 45
  • 43
  • 41
  • 19
  • 19
  • 19
  • 14
  • 14
  • 10
  • 7
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (fixed cells) (IF/ICC)
  • Purification

    Purified by antigen-specific affinity chromatography followed by Protein A affinity chromatography

    Isotype

    IgG
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    200 μg/mL

    Buffer

    PBS,  pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    Store at 4 °C. Avoid exposure to light.
  • Target

    ADRP (PLIN2) (Perilipin 2 (PLIN2))

    Alternative Name

    Adipose Differentiation Related Protein

    Pathways

    Regulation of Lipid Metabolism by PPARalpha, Lipid Metabolism
You are here:
Chat with us!